Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-18 · accession 0001610717-24-000548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-20 | 2024-12-18 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +30.8K | 355.9K | +9% | +$15.1K |
| D | 2024-12-20 | 2024-12-18 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -30.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-18 | M | A | 30,846 | $0.49 | 355,902 | D | — | — | (F1) Includes 167,125 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-18 | M | D | 30,846 | $0.00 | 0 | D | $0.49 · 2020-12-01 to 2027-03-20 | 30,846 Common Stock |